Skip to main content
. 2014 May 20;9(5):e97891. doi: 10.1371/journal.pone.0097891

Table 1. Elevated stearic acid levels in SACPD-C mutants.

Palmitic Acid (16∶0) Stearic Acid (18∶0) Oleic Acid (18∶1) Linoleic Acid (18∶2) Linolenic Acid (18∶3) n
W82 10.0±0.2 4±0.1 20.6±0.5 57.0±0.5 8.3±0.2 6
15073 SACPD-CG224E 8.1±0.4 12.1±1.2 15.9±0.6 55.0±1.3 8.8±0.6 6
1.3e−6* 1.8e−8* 4.6e−8* 0.0055 * 0.13
14197 SACPD-CY211C 8.8±0.4 12.1±3.5 20.0±2.9 51.6±0.7 7.6±0.6 3
1.25e−4* 5.3e−4* 0.62 2.4e−6* 0.0044*
18190 SACPD-CA218E 8.5±0.6 13.5±0.6 14.8±0.2 53.8±0.4 9.3±0.3 3
4.2e−4* 1.8e−9* 2.6e−7* 1.8e−5* 5.0e−4*
18948 SACPD-CH223R 10.1±0.5 9.5±1.3 17.4±0.6 54.9±1.1 8.1±0.4 4
0.75 4.4e−6* 1.3e−5* 0.0034* 0.26
18610 SACPD-CA239T 9.45±0.6 6.1±1.2 22.2±1.2 54.1±2.0 8.1±0.9 6
0.032* 0.0021* 0.0093* 0.0057* 0.57
21084 SACPD-CR329I 8.4±0.3 8.7±0.8 27.8±1.8 48.6±1.4 6.5±0.8 4
0.79 5.3e−4* 0.016 0.51 0.77

Fatty acid levels were averaged for n homozygous M4 or M5 lines for each mutation, and averages and standard deviations are shown. p-value (in italics) was calculated from a two-tailed, type 2 t-test for the average fatty acid level in each mutant relative to the Williams-82 (W82) wild type control. Single asterix indicates p-values that are significant at the p<0.05 level.